Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children
- PMID: 11598611
- DOI: 10.1067/mpd.2001.118195
Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children
Abstract
Tissue plasminogen activator was used to treat 228 children with 320 central venous catheter (CVC) occlusion events. Patency was restored in 91% of CVCs after 1 to 3 treatments, with no adverse events. Tissue plasminogen activator is effective in restoring patency to occluded CVCs and is a viable alternative to CVC removal or urokinase treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
